申请人:Hoechst Aktiengesellschaft
公开号:US05977151A1
公开(公告)日:1999-11-02
A compound of the formula ##STR1## where R.sup.1 is the radical of the formula II or III ##STR2## is suitable for the production of a pharmaceutical for the treatment of inflammations, carcinomatous diseases, or autoimmune diseases. A compound of the formula IV ##STR3## is suitable for the production of specific antibodies against a compound of the formula I for the discovery of specific-binding proteins from cell extracts, serum, blood, or synovial fluids, for the purification of proteins, for the modification of microtiter plates, or for the preparation of chromatography material, in particular of affinity chromatography material, and for use in diagnostics.
公式为##STR1##的化合物,其中R.sup.1是公式II或III的基团##STR2##,适用于制备用于治疗炎症、癌症或自身免疫性疾病的制药。公式IV的化合物##STR3##适用于制备针对公式I的特异性抗体,以便从细胞提取物、血清、血液或滑液中发现特异性结合蛋白,用于蛋白质纯化、微孔板修饰、层析材料的制备,特别是亲和层析材料的制备,并用于诊断。